To explore transcriptional activators of METTL8 in glioma, we conducted correlative analysis of METTL8 expression with that of established GBM-relevant transcription factors in gliomas using TCGA, NCI REMBRANDT and Gravendeel datasets [22–26]. Here, METTL8 is linked to central nervous system cancer.